Inflammatory Mechanisms in Heart Failure with Preserved Ejection Fraction

被引：12
|
作者：
Daou, Daniel [1 ]
Gillette, Thomas G. [1 ]
Hill, Joseph A. [1 ,2 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX USA
来源：
PHYSIOLOGY | 2023年 / 38卷 / 05期
基金：
美国国家卫生研究院;
关键词：
heart failure; inflammation; meta-inflammation; myocardial remodeling; EPICARDIAL ADIPOSE-TISSUE; TUMOR-NECROSIS-FACTOR; HIGH-DENSITY-LIPOPROTEINS; CLONAL HEMATOPOIESIS; CARDIAC-HYPERTROPHY; MYOCARDIAL FIBROSIS; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; MACROPHAGE POLARIZATION; DIASTOLIC DYSFUNCTION;
D O I：
10.1152/physiol.00004.2023
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
Heart failure with preserved ejection fraction (HFpEF) is now the most common form of heart failure and a significant public health concern for which limited effective therapies exist. Inflammation triggered by comorbidity burden is a critical element of HFpEF pathophysiology. Here, we discuss evidence for comorbidity-driven systemic and myocardial inflammation and the mechanistic role of inflammation in pathological myocardial remodeling in HFpEF.
引用
收藏
页码：217 / 230
页数：14
相关论文
共 50 条
  • [1] Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms
    Fopiano, Katie Anne
    Jalnapurkar, Sawan
    Davila, Alec C.
    Arora, Vishal
    Bagi, Zsolt
    CURRENT CARDIOLOGY REVIEWS, 2022, 18 (02) : 6 - 14
  • [2] Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
    Franssen, Constantijn
    Chen, Sophia
    Unger, Andreas
    Korkmaz, H. Ibrahim
    De Keulenaer, Gilles W.
    Tschoepe, Carsten
    Leite-Moreira, Adelino F.
    Musters, Rene
    Niessen, Hans W. M.
    Linke, Wolfgang A.
    Paulus, Walter J.
    Hamdani, Nazha
    JACC-HEART FAILURE, 2016, 4 (04) : 312 - 324
  • [3] Insight into the Pro-inflammatory and Profibrotic Role of Macrophage in Heart Failure With Preserved Ejection Fraction
    Shen, Jin-lian
    Xie, Xiao-jie
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 76 (03) : 276 - 285
  • [4] Research Update on the Pathophysiological Mechanisms of Heart Failure with Preserved Ejection Fraction
    Zhou, Yuying
    Zhu, Yunlong
    Zeng, Jianping
    CURRENT MOLECULAR MEDICINE, 2023, 23 (01) : 54 - 62
  • [5] Epidemiology and pathogenesis of heart failure with preserved ejection fraction
    Nair, Nandini
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (04) : 531 - 540
  • [6] Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
    Sabbah, Michael S.
    Fayyaz, Ahmed U.
    de Denus, Simon
    Felker, G. Michael
    Borlaug, Barry A.
    Dasari, Surendra
    Carter, Rickey E.
    Redfield, Margaret M.
    CIRCULATION-HEART FAILURE, 2020, 13 (08) : E006414
  • [7] Inflammatory Pathways and Their Implications in Heart Failure With Preserved Ejection Fraction
    Segar, Matthew W.
    Coulter, Stephanie A.
    TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (05)
  • [8] Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
    Borlaug, Barry A.
    CIRCULATION JOURNAL, 2014, 78 (01) : 20 - 32
  • [9] Heart failure with preserved ejection fraction: from mechanisms to therapies
    Lam, Carolyn S. P.
    Voors, Adriaan A.
    de Boer, Rudolf A.
    Solomon, Scott D.
    van Veldhuisen, Dirk J.
    EUROPEAN HEART JOURNAL, 2018, 39 (30) : 2780 - 2792
  • [10] Targeting the Metabolic-Inflammatory Circuit in Heart Failure With Preserved Ejection Fraction
    Yap, En Ping
    Kp, Myu Mai Ja
    Ramachandra, Chrishan J.
    CURRENT HEART FAILURE REPORTS, 2022, 19 (03) : 63 - 74
12345